Grants and Contributions

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of: - Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs. - Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions. The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of: - Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs. - Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions. The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment

The Heart and Stroke Foundation of Canada (Heart & Stroke) is prioritizing the development of a Congenital Heart Disease (CHD) Strategy for Canada to enable optimal wellness and health outcomes for people living with CHD, their families and caregivers. As a key pillar of this strategy, Heart & Stroke together with Brain Canada, the Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health (ICRH) and CIHR Institute of Genetics (IG) are collectively committing $5,250,000 CAD over five (5) years to fund the Congenital Heart Disease (CHD) Team Grants Funding Opportunity.

The specific objectives of this funding opportunity are to:

• Address the biological, social, environmental and/or behavioural effects on lung health through rigorous research approaches informed by intersectional analyses;
• Coordinate the collection and sharing of data to understand, prevent, detect and manage lung health to improve reproducibility and rigour of research results;
• Disseminate, inform and implement high-quality evidence into practice and policy for improved and more equitable health outcomes;
• Strengthen and promote lung health research capacity through interdisciplinary and experiential-based approaches to foster the next generation of lung health researchers;
• Meaningfully integrate equity, diversity and inclusion analyses and considerations within research studies and teams;
• Broadly strengthen the respiratory health and wellness of people living in Canada with meaningful consideration of historically excluded groups and Indigenous Peoples (First Nations, Inuit, and Métis).

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of: - Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs. - Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions. The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of: - Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs. - Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions. The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of: - Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs. - Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions. The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment

• The CIHR HIV/AIDS and STBBI Research Initiative, under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI. This includes but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations and strategic directions identified in the CIHR HIV/AIDS Research Initiative: Strategic Plan (2015-2020) is highly encouraged.

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic health research trainees;
• To provide a reliable supply of highly skilled and qualified researchers.